Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6002 USD | -9.06% | +18.38% | +119.85% |
11:20am | North American Morning Briefing : Stocks Set for -2- | DJ |
Feb. 23 | BrainStorm Cell Therapeutics Submits Special Protocol Assessment Request to FDA for Phase 3b Trial of NurOwn in ALS | CI |
- Stock
- Equities
- Stock Brainstorm Cell Therapeutics Inc. - Nasdaq
- News Brainstorm Cell Therapeutics Inc.